Now that we know the neurotransmitters affected, it has been determined that serotonin-norepinephrine reuptake inhibitors (SNRIs) are actually MAO-inhibitors.

Question

Quizplus · Accepted Answer

SNRIs are not MAO-inhibitors. They work by blocking the reuptake of both serotonin and norepinephrine in the brain, thereby increasing the levels of these neurotransmitters in the synaptic cleft. MAO-inhibitors, on the other hand, inhibit the activity of the enzyme monoamine oxidase, which breaks down serotonin, norepinephrine, and other neurotransmitters.

Now That We Know the Neurotransmitters Affected, It Has Been